Technical amendment to Medicines Act

 Technical amendment to Medicines Act

The Government is aware of a High Court decision today about processes to grant provisional consent to some approved medicines, and is making a technical amendment to modernise the law.

The Court has said that while the Minister of Health can, under Section 23 of the Medicines Act, grant approval for Medsafe-approved medicines to be used by a limited number of patients, it’s arguable whether it can be done for the whole population.

Health Minister Andrew Little says Section 23 has been used over 40 years by successive Governments to grant early access to approved therapeutic substances when it is in the public good.

“The law has for some time now, lacked clarity over how it can be applied,” Andrew Little said.

“We already knew the Medicines Act was out of date, which is why we were planning to replace it with a new Therapeutic Products Act.

“Treatments approved under Section 23 go through a rigorous Medsafe approvals process. There are occasions when the health needs of a population call for urgent access to a medicine, vaccine or treatment and we need to keep this option available for some circumstances.

“There are six products currently in use under Section 23, including two types of contraceptives, two pandemic flu vaccines, the Pfizer COVID-19 vaccine and an electrolyte solution used in hospitals, potentially affected by the decision.

“The Government will introduce a Bill tomorrow to make sure New Zealanders continue to have timely access to the medicines and treatments they need. The Medicines Amendment Bill is expected to be passed under urgency tomorrow in order to protect New Zealanders early access to medicines when needed,” Andrew Little said.

The Therapeutic Products Bill that will replace the outdated Medicines Act is expected to be introduced into Parliament next year.


For further information contact: Adelia Hallett 021 802 905

Ngā mihi

Adelia Hallett
Senior Press Secretary to Hon Andrew Little MP

DDI +64 4 817 9685 | Mobile +64 21 802 905 | Email

Office of Hon Andrew Little MP, Minister of Health, Lead Coordination Minister for the Government’s Response to The Royal Commission’s Report into the Terrorist Attack on the Christchurch Mosques, Minister for Treaty of Waitangi Negotiations, Minister Responsible for the NZSIS, Minister Responsible for the GCSB, Minister Responsible for Pike River Re-entry
Reception +64 4 817 8707 | Ministerial Email | Web | Postal Freepost Parliament, Private Bag 18 041, Parliament Buildings, Wellington 6160, New Zealand

Please note information about meetings related to the Ministers’ portfolios will be proactively released (this does not include personal or constituency matters). For each meeting in scope, the summary would list: date, time (start and finish), brief description, location, who the meeting was with, and the portfolio. If you attend a meeting with the Minister on behalf of an organisation, the name of the organisation will be released. If you are a senior staff member at an organisation, or meet with the Minister in your personal capacity, your name may also be released. The location of the meeting will be released, unless it is a private residence. The proactive release will be consistent with the provisions in the Official Information Act, including privacy considerations. Under the Privacy Act 1993 you have the right to ask for a copy of any personal information we hold about you, and to ask for it to be corrected if you think it is wrong. If you’d like to ask for a copy of your information, or to have it corrected, or are concerned about the release of your information in the meeting disclosure, please contact the sender. You can read more about the proactive release policy at

Authorised by Hon Andrew Little MP, Parliament Buildings, Wellington 6160, New Zealand

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: